Industry landscapes
The companies, capital and talent shaping healthtech in Austin. Find the leaders. Understand the segments. See where the activity is.
An industry ecosystem,
measured in context.
24 featured companies from the funding, hiring, revenue and team-size leaderboards.
Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗
Recently founded means a recorded 2023–2026 founding year and no recorded parent, acquirer or public-company status. These companies are not labelled startups without that separate classification.
Explore classified startups in Radar ↗A few useful ratios bring the size of this ecosystem into perspective.
36 of 485 tracked companies have open roles.
138 of 485 tracked companies have a recorded round.
Share of disclosed capital received by the three largest recorded recipients.
Midpoint of 253 rounds with a disclosed amount.
Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 25.3% of disclosed capital, while 71.5% of tracked companies have no recorded funding round.
Explore the segments →Recorded company formation and disclosed funding across the complete annual series shown.
Sum of recorded funding rounds · USD
| Year | Funding (USD) | Founded | Raising |
|---|---|---|---|
| 2016 | $120.48M | 33 | 19 |
| 2017 | $77.1M | 35 | 17 |
| 2018 | $147.25M | 31 | 23 |
| 2019 | $139.61M | 27 | 21 |
| 2020 | $415.17M | 30 | 29 |
| 2021 | $430.12M | 22 | 27 |
| 2022 | $445.85M | 29 | 19 |
| 2023 | $139.18M | 22 | 19 |
| 2024 | $169.51M | 18 | 11 |
| 2025 | $711.02M | 5 | 23 |
Share of all disclosed company funding.
294 recorded rounds since 2016
Recorded participation in healthtech company rounds since 2016.
Backed by Menlo Ventures and Thrive Capital and others.
Backed by Standard Capital and Pear VC and others.
Backed by .
Backed by United Ventures and Vento and others.
Backed by .
Backed by Redpoint Ventures and Andreessen Horowitz and others.
Backed by BlackRock and TCG and others.
Backed by Justin Mateen and Mike Novogratz and others.
Backed by Lightspeed Venture Partners and Tiger Global Management and others.
Backed by Menlo Ventures and Thrive Capital and others.
Backed by Health Quest Capital.
Backed by J P Morgan and Thrive Capital and others.
Backed by Spectrum Equity.
Backed by CRG.
Backed by Arch Venture Partners.
Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.
Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.
FY2025 · company accounts; aggregate reporting threshold not met · 2 reporting entities from 4 eligible matches.
Sum of reporting-entity revenue; not Austin market sales.
Combined result for the same cohort.
Combined net income ÷ combined revenue.
The middle covered reporting entity.
None of 2 covered entities.
Share of covered revenue from the five largest entities.
Reported cohort totals by year; coverage is stated for every period.
Bar height shows revenue. Changes in coverage can affect totals.
FY2025 · 2 reporting entities
Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.
| Company / reporting entity | Revenue | Net profit / loss | Net margin | Revenue growth | Total assets |
|---|---|---|---|---|---|
| Aspira Women's Health ↗926617 | $9.2m | $-12.8m | -138.7% | — | — |
| HeartSciences ↗1468492 | $0.0m | $-8.8m | -201499.5% | — | — |
Explore full company accounts and filings.
Choose “View accounts” to inspect an available company preview.
Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.
| Industry | Covered / eligible | Revenue total | Median revenue | Net profit / loss | Aggregate margin | Profitable share | Overlap |
|---|
Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.
Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.
The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.
Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.
How the Austin companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.
9 of the 485 companies on this page carry a measured traffic record (1.9%); these are the largest of those, by monthly visits. The median among them is 232,396 visits.
| Company | Monthly visits | Authority | Mobile |
|---|---|---|---|
| Truemedtruemed.com | 652,049 | 47 | 66.2% |
| Everlywelleverlywell.com | 502,873 | 62 | 65% |
| SLEEP DISORDERS CENTER OF CENTRAL T EXASsleepdoctor.com | 397,286 | 52 | 63.5% |
| WeInfuseweinfuse.com | 278,600 | 31 | 51.7% |
| Crystal Practice Managementcrystalpm.com | 232,396 | 32 | 72.4% |
| Dr.Galendrgalen.org | 136,080 | 28 | 36.2% |
| Nourishusenourish.com | 106,481 | 42 | 82.1% |
| Season Healthseasonhealth.com | 50,196 | 38 | 71% |
| Shmoodyshmoody.com | 565 | 21 | 0% |
Visits and authority are third-party web estimates, not company-reported figures.
50 of these companies (10.3%) publish at least one Android app — 66 apps in all, carrying 4.3M installs between them.
| App | Installs | Rating | Store category |
|---|---|---|---|
| RxSaver – Prescription CouponsRxSaver | 2.3M | 4.6 | Medical |
| Baritastic - Bariatric TrackerBaritastic | 834.4K | 4.7 | Medical |
| Shmoody: Improve Your Moodshmoody | 386.9K | 4.7 | Health & Fitness |
| NailKeeper - Stop Biting NailsNailKeeper | 226.3K | 4.1 | Health & Fitness |
| Nourish: Eating Well Made EasyNourish | 148.6K | 4.7 | Health & Fitness |
| Bác sĩ toàn cầu-Vi HealthcareGlobeDr | 74.1K | — | Health & Fitness |
| Body InteractBody Interact | 55.7K | 3.1 | Education |
| Loud and Clear for Parkinson\'sLoud and Clear | 46K | 3.5 | Medical |
| Health WalletHealth Wallet | 42.1K | 2.8 | Health & Fitness |
| Function HealthFunction Health | 31.7K | 3.6 | Health & Fitness |
Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.
The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q2–2026Q2).
| Segment | Apps | Installs | Leading app | Release trend |
|---|---|---|---|---|
| Healthcare Booking Platforms | 15 | 2.5M | RxSaver – Prescription Coupons 2.3M | |
| Disease Self Management | 25 | 1.6M | Baritastic - Bariatric Tracker 834.4K | |
| Fitness & Wellness Tech | 6 | 400.3K | Shmoody: Improve Your Mood 386.9K | |
| Healthcare It | 34 | 157K | Body Interact 55.7K | |
| Wearable Technology | 12 | 24.2K | Frontier X 10.5K | |
| Hrtech | 4 | 20.4K | Quinable 17.3K | |
| Sharing Economy | 3 | 17.6K | Facility App 254 | |
| Cardiac And Vascular Disorders | 4 | 11K | Frontier X Plus 269 |
A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.
New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.
Darker bars are new releases, lighter bars apps updated. 60 of 66 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.
Explore the segments behind the headline numbers.
Rank segments by scale, hiring or disclosed funding.
Companies can sit in several segments. Counts and funding overlap.
The largest measured segment in this report snapshot.
21 companies hiring · $2.49B disclosed funding
Explore in RadarCommon revenue models; a company can use more than one.
Recorded corporate activity linked to companies in this landscape.
Global investment firm Carlyle (NASDAQ: CG) today announced it has acquired a majority stake in Knack RCM (“Knack”) and EqualizeRCM (“Equalize”), two leading U.S. healthcare revenue cycle management (“RCM”) providers, to create an AI-native, global, multi-specialty RCM platform.
PCSI has acquired CareStarter, an automated care management software developer, to expand its healthcare technology capabilities.
Function Health has acquired Getlabs, an online at-home lab sample collection service.
Last mile delivery firm, Serve Robotics on Tuesday announced plans to acquire Diligent Robotics
Prospyr , a leading provider of all-in-one practice management software for aesthetics and wellness practices, today announced a strategic growth investment from Five Elms Capital.
Curative – $150.0M
The acquisition of Iodine Software expanded Waystar's total addressable market by more than 15% and accelerated innovation, enhancing their AI-powered platform.
On October 28, 2025, Genprex, Inc. announced a securities purchase agreement for a registered direct offering of 377,780 shares of common stock at $9.00 per share, expected to close on October 29, 2025. The offering includes a concurrent private placement of warrants for up to 755,560 shares, with potential gross proceeds of $6.6 million if fully exercised. The company plans to use the net proceeds, estimated at $3.0 million, for working capital and general corporate purposes.
Raised $21 million in Series A funding.
Nourish, a virtual nutrition care platform, has closed a $70 million Series B round to accelerate product development, expand its network of Registered Dietitians, grow its team and strengthen partnerships.
Top 10 categories among 120 recorded events in the 24-month window.
6 tracked people moves
Resignation Previously Advisory board member
Appointment Chairman
Resignation Previously Advisory board member
Promotion Chief Administrative Officer
Promotion Chief Commercial Officer
Appointment Chief Product and Technology Officer
1 companies with reported reductions
Scale not stated rolesconsolidation
3 recorded events
U.S. Food and Drug Administration
submitted for 510(k) premarket clearanceU.S. Food and Drug Administration
trading haltedNasdaq
6 tracked suits
COVID-19 testing disputeCivil · Settled
merger enforcement / acquisition enjoinCivil · Filed
Company-linked deal reports; status is preserved as recorded.
| Acquirer → target | Status | Date | Value / context |
|---|---|---|---|
| carlyle→EqualizeRCM ↗ | Announced | 2026-05-04 | Not stated in snapshot |
| Function Health→getlabs | Announced | 2026-04-14 | Not stated in snapshot |
| pcsi→Carestarter ↗ | Announced | 2026-04-14 | Not stated in snapshot |
| serve robotics→Diligent Robots ↗ | Announced | 2026-01-31 | $29.0M |
| waystar→Iodine Software ↗ | 2025-10-30 | Not stated in snapshot | |
| Function Health→ezra | Completed | 2025-09-04 | Not stated in snapshot |
A discussion or rumour is not a completed transaction. An unstated value is not zero.
1,261 postings in the preceding 12 months. The full 1,858-posting snapshot covers 62 employers.
49 tracked postings mention remote work.
406 postings specify a level.
Top skills across 1,858 tracked postings in the available jobs snapshot.
Median across 74 postings with pay data, expressed in USD.
| Company | Employees |
|---|---|
| Curative ↗ | 2,251 |
| ESO ↗ | 645 |
| Everly Health ↗ | 573 |
| healthtronics ↗ | 500 |
| HNI Healthcare ↗ | 222 |
| Nourish ↗ | 178 |
| The Helper Bees ↗ | 164 |
| Orangetheory Fitness | Austin Fitness Group ↗ | 117 |
281 founders and chief executives across 190 companies.
All Bridges Legal, ex-Chavez & Gertler, Lerach Coughlin. University of Pennsylvania BA 2001, Stanford Law School JD 2005
Ex- Founder & CEO RecruitHere, Favor Delivery, Google, International Biomedical, Medtronic. St.Edward's University BBA 2011
Diligent Robotics, ex-Georgia Institute Of Technology, ex-Google, Georgia Institute of Technology, 2017
Ex-The CDI Group. Southern Methodist University 2007, University of North Texas 2009
Founder Georgetown Living, ex-AustinUP. The University of Texas at Austin BS 2003, Baylor College of Medicine PhD 2010
Brigham Young University BS 2008, University of Houston MBA 2012
Venture Partner - Social Impact Capital
Strategic Partner - Trinity Investors. The University of Texas at Austin Bachelor of Business Administration 2001
Ex-Amazon, Hubbard One. Northwestern University BS 2002
Ex-Remote, Branded.me, Dock.
Expressable, ex-Riverkids Pediatric Home Health Therapy Agency, ex-Cole Pediatric Therapy, Northwestern University
Babson Diagnostics, ex-Siemens Healthineers, ex-Siemens Healthcare, The Johns Hopkins University, 2001
36 profiles with education records.
8 profiles with prior-work records.
Profiles cover recorded founders and leaders; contact details remain in Radar.
14,714 articles in the measured 12-month window.
Healthtech coverage tagged Austin · articles per complete quarter
| Quarter | Articles |
|---|---|
| 2021Q2 | 2,962 |
| 2021Q3 | 4,567 |
| 2021Q4 | 2,809 |
| 2022Q1 | 3,713 |
| 2022Q2 | 4,170 |
| 2022Q3 | 2,893 |
| 2022Q4 | 2,895 |
| 2023Q1 | 3,791 |
| 2023Q2 | 4,268 |
| 2023Q3 | 3,239 |
| 2023Q4 | 4,216 |
| 2024Q1 | 4,174 |
| 2024Q2 | 4,142 |
| 2024Q3 | 3,647 |
| 2024Q4 | 4,138 |
| 2025Q1 | 5,808 |
| 2025Q2 | 3,554 |
| 2025Q3 | 4,961 |
| 2025Q4 | 2,979 |
| 2026Q1 | 3,403 |
Article volume measures coverage, not market sales.
126 recorded company events across 29 companies; percentages use that event total.
Healthtech coverage tagged Austin · ranked by full-period article count.
Recent and prior counts use the source comparison windows.
United States comparison coverage
| Keyword | Recent | Prior | Change |
|---|---|---|---|
| foreign policy analysis | 7,248 | 4,848 | 50% |
| multilateral diplomacy | 7,093 | 4,378 | 62% |
| national security strategy | 7,075 | 3,119 | 127% |
| bilateral trade | 5,915 | 4,221 | 40% |
| diplomatic engagements | 5,572 | 3,522 | 58% |
| vaccine candidates | 5,445 | 1,402 | 288% |
| vaccine trials | 4,931 | 1,374 | 259% |
| vaccination campaigns | 4,914 | 1,021 | 381% |
| countries | 4,204 | 1,897 | 122% |
| vaccine immunogenicity | 4,034 | 1,074 | 276% |
| olympic team selections | 1,407 | 2,836 | -50% |
| olympic trials | 1,103 | 2,360 | -53% |
| ceasefire violations | 903 | 1,703 | -47% |
| summer olympics athletics | 209 | 1,564 | -87% |
| electioneering tactics | 665 | 1,562 | -57% |
United States comparison coverage
territories, disputed islands, vaccine mandate compliance
42.5% critical · 22.3% positivepublic health funding, investment deal, inflation reports fx
46.9% critical · 41.2% positiveearnings report, quarterly results, quarterly financials
35.3% critical · 45.4% positiveHealthtech coverage tagged Austin. Topic labels describe recorded classifications and can include broad context.
8,843 papers in the recorded india scope.
Tone counts: 7,674 positive · 337 neutral · 832 negative.
Landmark: Implementation strategies: recommendations for specifying and reporting
Landmark: Realist synthesis: illustrating the method for implementation research
Landmark: Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science
Common problems researchers identify · 0118.0% of this theme group
Researchers highlight obstacles in developing effective drugs and pharmacogenomic approaches.
Drug discovery (305) · Drug (169) · Pharmacogenomics (141) · Drug development (96)
Cancer epigenetics drug discovery and development: the challenge of hitting the mark
Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations
| Year | Share index |
|---|---|
| 2022 | 155.8 |
| 2023 | 160.7 |
| 2024 | 168.0 |
| 2025 | 209.7 |
Common problems researchers identify · 0218.0% of this theme group
Studies point to inclusion, evaluation, and equity issues in remote care.
Telemedicine (687) · Telehealth (648) · Health care (347) · Nursing (98)
Ensuring full participation of people with disabilities in an era of telehealth
Strategies for Evaluating Telehealth
| Year | Share index |
|---|---|
| 2022 | 541.2 |
| 2023 | 553.5 |
| 2024 | 538.6 |
| 2025 | 840.0 |
Common problems researchers identify · 0313.6% of this theme group
Work examines shortcomings in administration, nursing, and informatics for chronic and public health services.
Health administration (209) · Nursing research (154) · Health informatics (234) · Public health (215)
Is Europe putting theory into practice? A qualitative study of the level of self-management support in chronic care management approaches
Understanding integrated service delivery: a scoping review of models for noncommunicable disease and mental health interventions in low-and
| Year | Share index |
|---|---|
| 2022 | 22.0 |
| 2023 | 20.3 |
| 2024 | 26.9 |
| 2025 | 43.6 |
Common problems researchers identify · 0413.6% of this theme group
Authors discuss difficulties in applying personalized approaches to cancer and other diseases.
Precision medicine (602) · Personalized medicine (282) · Cancer (105) · Disease (121)
The growing role of precision and personalized medicine for cancer treatment
Precision Medicine: Disease Subtyping and Tailored Treatment
| Year | Share index |
|---|---|
| 2022 | 764.3 |
| 2023 | 1049.9 |
| 2024 | 798.6 |
| 2025 | 777.4 |
Common problems researchers identify · 0513.5% of this theme group
Papers critique obstacles to integrating digital tools within universal health coverage.
Digital health (431) · Health care (328) · Health informatics (149) · Informatics (73)
Technology and Universal Health Coverage: Examining the role of digital health
Digital Health and Health Systems of the Future
| Year | Share index |
|---|---|
| 2022 | 540.1 |
| 2023 | 553.1 |
| 2024 | 540.7 |
| 2025 | 849.1 |
Common problems researchers identify · 0613.1% of this theme group
Research flags inequities and challenges that emerged during COVID‑19 remote care.
Pandemic (570) · Coronavirus disease 2019 (384) · 2019-20 coronavirus outbreak (108) · Telemedicine (386)
Telemedicine and health access inequalities during the COVID-19 pandemic
Examining telehealth use among primary care patients, providers, and clinics during the COVID-19 pandemic
| Year | Share index |
|---|---|
| 2022 | 661.4 |
| 2023 | 443.9 |
| 2024 | 330.0 |
| 2025 | 212.6 |
Common problems researchers identify · 0710.3% of this theme group
Studies emphasize the need for robust standards and usability testing for devices and wearables.
Medical device (152) · Wearable computer (47) · Health care (152) · Food and drug administration (36)
The Need to Apply Medical Device Informatics in Developing Standards for Safe Interoperable Medical Systems
Medical Device Usability Analyses
| Year | Share index |
|---|---|
| 2022 | 564.5 |
| 2023 | 577.8 |
| 2024 | 564.0 |
| 2025 | 876.1 |
Cautions · 0124.5% of this theme group
Analyses warn of economic and clinical risks when scaling home telehealth.
Telemedicine (394) · Telehealth (307) · Medical emergency (63) · Health care (134)
Home telehealth for chronic disease management: A systematic review and an analysis of economic evaluations
Transition to telehealth
| Year | Share index |
|---|---|
| 2022 | 215.3 |
| 2023 | 197.2 |
| 2024 | 209.5 |
| 2025 | 199.0 |
Cautions · 0215.8% of this theme group
Authors caution about planning, implementation, and evaluation pitfalls in digital health systems.
Health informatics (124) · Health administration (73) · Nursing research (49) · Health care (117)
A systematic approach to the planning, implementation, monitoring, and evaluation of integrated health services
INFORMATION SYSTEMS IN HEALTH MANAGEMENT: INNOVATIONS AND CHALLENGES IN THE DIGITAL ERA
| Year | Share index |
|---|---|
| 2022 | 22.0 |
| 2023 | 20.3 |
| 2024 | 26.9 |
| 2025 | 43.6 |
Cautions · 0315.4% of this theme group
Research highlights patient perception and clinician concerns during pandemic‑era remote care.
Pandemic (268) · Coronavirus disease 2019 (208) · Telemedicine (212) · Telehealth (177)
Patient Perception of Telehealth Services for Breast and Gynecologic Oncology Care during the COVID-19 Pandemic: A Single Center Survey-base
Community Mental Health Clinicians’ Perspectives on Telehealth During the COVID-19 Pandemic: Mixed Methods Study
| Year | Share index |
|---|---|
| 2022 | 548.5 |
| 2023 | 379.1 |
| 2024 | 244.3 |
| 2025 | 190.4 |
Cautions · 0414.4% of this theme group
Papers discuss variability and implementation hurdles in genetic testing for drug response.
Pharmacogenomics (86) · Drug discovery (91) · Drug (59) · Pharmacology (33)
Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and <scp>Meta‐Analysis</scp> of Prospective, Controlled Clinic
Warfarin Pharmacogenomics in Diverse Populations
| Year | Share index |
|---|---|
| 2022 | 155.8 |
| 2023 | 160.7 |
| 2024 | 168.0 |
| 2025 | 209.7 |
Cautions · 0511.4% of this theme group
Studies note promise and constraints of technology‑based psychological treatments.
Psychological intervention (118) · Digital health (104) · Mental health (62) · Intervention (56)
Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review
Digitization and its Discontents: The Promise and Limitations of Digital Mental Health Interventions
| Year | Share index |
|---|---|
| 2022 | 784.7 |
| 2023 | 800.0 |
| 2024 | 802.5 |
| 2025 | 1143.3 |
Cautions · 0611.3% of this theme group
Authors point to gaps in biomarker validation and therapeutic targeting for cancer.
Precision medicine (127) · Personalized medicine (61) · Cancer (49) · Oncology (37)
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials
Mechanism-Centric Approaches for Biomarker Detection and Precision Therapeutics in Cancer
| Year | Share index |
|---|---|
| 2022 | 764.3 |
| 2023 | 1049.9 |
| 2024 | 798.6 |
| 2025 | 777.4 |
Cautions · 077.1% of this theme group
Research raises caution about data quality and bias when applying AI to personalized care.
Applications of artificial intelligence (19) · Health care (53) · Precision medicine (36) · Personalized medicine (28)
Leveraging Artificial Intelligence for Predictive Healthcare: A Data-Driven Approach to Early Diagnosis and Personalized Treatment
Advancements in the treatment of autoimmune diseases: Integrating artificial intelligence for personalized medicine
| Year | Share index |
|---|---|
| 2022 | 543.5 |
| 2023 | 558.4 |
| 2024 | 545.5 |
| 2025 | 874.8 |
Opportunities · 0118.5% of this theme group
Investigations reveal improved access and family engagement through remote care models.
Telehealth (669) · Telemedicine (567) · Pandemic (136) · Coronavirus disease 2019 (120)
Urgent and non-emergent telehealth care for seniors: Findings from a multi-site impact study
Using inpatient telehealth for family engagement: A mixed methods study of perceptions from patients, families, and care team providers
| Year | Share index |
|---|---|
| 2022 | 548.9 |
| 2023 | 380.0 |
| 2024 | 246.2 |
| 2025 | 194.7 |
Opportunities · 0216.2% of this theme group
Papers showcase in‑silico tools accelerating discovery and design of novel therapeutics.
Drug discovery (597) · Computational biology (310) · Chemical space (104) · Drug (199)
Assessing molecular docking tools: understanding drug discovery and design
Landscape of <i>In Silico</i> Tools for Modeling Covalent Modification of Proteins: A Review on Computational Covalent Drug Discovery
| Year | Share index |
|---|---|
| 2022 | 182.1 |
| 2023 | 196.4 |
| 2024 | 225.2 |
| 2025 | 259.1 |
Opportunities · 0315.8% of this theme group
Research proposes frameworks for effective digital interventions across public health domains.
Digital health (225) · Health informatics (198) · Health care (254) · Public health (106)
IDEAS (Integrate, Design, Assess, and Share): A Framework and Toolkit of Strategies for the Development of More Effective Digital Interventi
Integrated Digital Mental Health Care: A Vision for Addressing Population Mental Health Needs
| Year | Share index |
|---|---|
| 2022 | 540.1 |
| 2023 | 553.1 |
| 2024 | 540.7 |
| 2025 | 849.1 |
Opportunities · 0415.7% of this theme group
Studies identify new molecular regulators and drug candidates through advanced screening.
Drug discovery (269) · Drug (133) · Pharmacology (64) · In vivo (56)
Development and Characterization of Selective FAK Inhibitors and PROTACs with <i>In Vivo</i> Activity
A kinase to cytokine explorer to identify molecular regulators and potential therapeutic opportunities
| Year | Share index |
|---|---|
| 2022 | 512.3 |
| 2023 | 527.8 |
| 2024 | 495.0 |
| 2025 | 494.4 |
Opportunities · 0513.1% of this theme group
Work demonstrates rapid tumor profiling to guide personalized cancer treatment.
Cancer (230) · Precision medicine (278) · Oncology (89) · Breast cancer (91)
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Systems approach for congruence and selection of cancer models towards precision medicine
| Year | Share index |
|---|---|
| 2022 | 893.2 |
| 2023 | 1222.6 |
| 2024 | 953.9 |
| 2025 | 908.7 |
Opportunities · 0611.3% of this theme group
Research expands phenome‑wide approaches to improve prediction and treatment across complex diseases.
Precision medicine (299) · Personalized medicine (212) · Disease (137) · Health care (84)
Phenome-Wide Association Studies as a Tool to Advance Precision Medicine
Precision medicine in complex diseases—Molecular subgrouping for improved prediction and treatment stratification
| Year | Share index |
|---|---|
| 2022 | 1258.8 |
| 2023 | 1116.7 |
| 2024 | 1011.1 |
| 2025 | 1302.9 |
Opportunities · 079.4% of this theme group
Papers develop remote monitoring and surgical robot technologies for real‑time patient care.
Wearable computer (90) · Remote patient monitoring (52) · Surgical robot (38) · Robot (36)
Development of a remote therapeutic monitoring platform: applications for movement disorders
IoT-enabled health monitoring system for real time patient care: Design and evaluation
| Year | Share index |
|---|---|
| 2022 | 32.7 |
| 2023 | 34.5 |
| 2024 | 35.7 |
| 2025 | 61.7 |
Orientation shares compared with 25,000 papers in the reference sample.
| Research orientation | This field | Reference sample |
|---|---|---|
| Problem-identifying | 32.5% | 9.9% |
| Promising | 29.8% | 37.1% |
| Descriptive | 14.9% | 17.5% |
| Breakthrough | 11.9% | 26.4% |
| Cautionary | 7.3% | 4.3% |
| Comparative | 2.9% | 3.8% |
| Critical | 0.7% | 0.9% |
Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.
| Concern / example paper | Papers | Share | Raised as a problem | Worldwide share |
|---|---|---|---|---|
| Privacy & surveillanceThe future of digital health with federated learning | 1,121 | 2.85% | 599 (53.4%) | 2.66% |
| Safety & misuseImpact of Rumors and Misinformation on COVID-19 in Social Media | 72 | 0.18% | 36 (50.0%) | 0.17% |
| Bias & fairnessPrivacy Protection, Personalized Medicine, and Genetic Testing | 29 | 0.07% | 16 (55.2%) | 0.06% |
| Hardware, e-waste & supply chainToo many bits: tackling the waste epidemic in digital medicine | 4 | 0.01% | 1 (25.0%) | 0.01% |
| Concentration of compute powerDemonopolizing Medical Knowledge | 3 | 0.01% | 2 (66.7%) | 0.01% |
| Energy & datacenter footprintSUSTAINABLE GREEN COMPUTING FOR MEDICAL APPLICATIONS: ADVANCING RESPONSIBLE HEALTHCARE IT | 2 | 0.01% | 2 (100.0%) | 0.01% |
| Labour & data workLabor markets for health supply chain management in Rwanda: a qualitative study of stakeholder perspectives | 2 | 0.01% | 2 (100.0%) | 0.01% |
| Carbon & emissions of computePotential reduction in healthcare carbon footprint by autonomous artificial intelligence | 1 | 0.0% | 0 (0.0%) | 0.0% |
| Water use | 0 | 0.0% | 0 (%) | 0.0% |
Institution and researcher rankings use citations to their covered work. Research scope: United States. This may be broader than the company geography.
Clear definitions for making better comparisons.
It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.
No. A company can belong to several segments, so segment counts and funding can overlap.
A dash or unavailable panel means the current reviewed source snapshot does not support that figure.
Company ecosystem snapshot: 6 August 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.
Canonical landscape ↗